Bisphenol, npcRNAs and Utero-Ovarian Feed-Back Control of Breast Cancer Chemosensitivity.
Yarpuzlu
Aysegul
A
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D001559:Benzhydryl Compounds; D001943:Breast Neoplasms / Q000188:drug therapy*; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000187:drug effects*; D004958:Estradiol / Q000031:analogs & derivatives / Q000494:pharmacology; D047628:Estrogen Receptor alpha / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D010053:Ovary / Q000187:drug effects / Q000378:metabolism; D010636:Phenols / Q000633:toxicity*; D022661:RNA, Untranslated / Q000235:genetics / Q000502:physiology*; D014599:Uterus / Q000187:drug effects / Q000378:metabolism; D014747:Vinblastine / Q000627:therapeutic use; D014874:Water Pollutants, Chemical / Q000633:toxicity*; D000098826:Bisphenol A Compounds
D000970:Antineoplastic Agents; D001559:Benzhydryl Compounds; D002945:Cisplatin; D004317:Doxorubicin; D004958:Estradiol; D047628:Estrogen Receptor alpha; D010636:Phenols; D022661:RNA, Untranslated; D014747:Vinblastine; D014874:Water Pollutants, Chemical; C006780:bisphenol A; D000098826:Bisphenol A Compounds